Drug Availability Update

Further to DrugAlert Volume 399, HPS Pharmacies wish to give notice that Pfizer Australia is now experiencing a supply interruption for Edronax® tablets as follows:

Edronax® 4mg Tablets
Reboxetine 4mg
ARTG 79745

This supply interruption is due to a delay in supply from the manufacturing facility. There are no safety concerns with this product. While wholesaler stocks of Edronax® are currently exhausted, HPS Pharmacies can still source a limited supply for the benefit of our clients. Normal supplies are expected to resume by the end of July 2018.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 999 543.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates